Privia director sells 18,113 shares via option exercise
Privia Health Group, Inc. director Matthew Shawn Morris reported option exercises paired with open-market sales of common stock.
Rhea-AI Filing Summary
Privia Health Group, Inc. director Matthew Shawn Morris reported option exercises paired with open-market sales of common stock. On May 1 and May 4, 2026, he exercised stock options covering a total of 18,113 shares at $2.00 per share and sold the same number of shares in open-market trades at weighted-average prices of about $24.99 and $24.96 per share under a Rule 10b5-1 trading plan. Following these transactions, he directly holds 68,188 common shares, plus indirect holdings of 11,998 shares held by a trust and 12,487 shares held by Emerald Family, LLC, and retains stock options covering 3,674,201 underlying shares expiring in 2033.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 18,113 shares ($416K approx. pre-tax spread)
Exercise and Sale
8 txns
Insider
Morris Matthew Shawn
Role
Director
Sold
18,113 shs ($453K)
Approx. gross sale proceeds
$453K
Approx. exercise cost
$36K
Approx. pre-tax spread
$416K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Purchase) | 1,017 | $0.00 | $0.00 |
| Exercise | Common Stock, par value $0.01 per share | 1,017 | $2.00 | $2K |
| Sale | Common Stock, par value $0.01 per share | 1,017 | $24.96 | $25K |
| Exercise | Stock Option (Right to Purchase) | 17,096 | $0.00 | $0.00 |
| Exercise | Common Stock, par value $0.01 per share | 17,096 | $2.00 | $34K |
| Sale | Common Stock, par value $0.01 per share | 17,096 | $24.99 | $427K |
| holding | Common Stock, par value $0.01 per share | -- | -- | -- |
| holding | Common Stock, par value $0.01 per share | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Purchase) — 3,674,201 contracts (Direct);
Common Stock, par value $0.01 per share — 68,188 shares (Direct);
Common Stock, par value $0.01 per share — 12,487 shares (Indirect, By Emerald Family, LLC);
Common Stock, par value $0.01 per share — 11,998 shares (Indirect, By Trust)
Footnotes (4)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.95 to $25.15 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.95 to $24.98 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F4. All stock options are fully vested and exercisable.
Key Figures
Shares sold: 18,113 shares
Sale price (May 1, 2026): $24.99 per share
Sale price (May 4, 2026): $24.96 per share
+5 more
8 metrics
Shares sold
18,113 shares
Open-market sales on May 1 and May 4, 2026
Sale price (May 1, 2026)
$24.99 per share
Weighted-average price for 17,096 shares sold
Sale price (May 4, 2026)
$24.96 per share
Weighted-average price for 1,017 shares sold
Option exercise price
$2.00 per share
Exercise price for 18,113 stock options
Direct holdings after trades
68,188 shares
Common stock directly owned after reported transactions
Trust holdings
11,998 shares
Common stock held indirectly by trust as of May 1, 2026
Emerald Family, LLC holdings
12,487 shares
Common stock held indirectly by Emerald Family, LLC
Remaining stock options
3,674,201 shares
Underlying shares for options outstanding after exercises, expiring 2033
Key Terms
Rule 10b5-1 trading plan, weighted average price, Stock Option (Right to Purchase), indirect ownership, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Purchase) financial
"security_title: "Stock Option (Right to Purchase)""
indirect ownership financial
"direct_or_indirect: "I", nature_of_ownership: "By Trust""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Privia Health (PRVA) director Matthew Shawn Morris report?
Matthew Shawn Morris reported exercising stock options for 18,113 Privia Health shares at $2.00 per share, then selling the same number of shares in open-market trades around $25 per share. These transactions were executed under a pre-arranged Rule 10b5-1 trading plan.
What stock option activity did Matthew Shawn Morris report for Privia Health (PRVA)?
He exercised stock options to acquire 18,113 Privia Health common shares at an exercise price of $2.00 per share. After these exercises, options remain outstanding covering 3,674,201 underlying shares of Privia Health common stock, with an expiration date in 2033.
What is the significance of the Rule 10b5-1 trading plan mentioned in the Privia Health (PRVA) filing?
A Rule 10b5-1 trading plan allows insiders to pre-schedule trades, helping manage potential insider-trading concerns. In this filing, Morris’s sales occurred under such a plan, meaning the timing and amounts were established earlier, independent of any later nonpublic company information.
AI-generated analysis. How Rhea-AI works. Not financial advice.
